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Abstract
Background: Candida parapsilosis is increasingly responsible for invasive candidiasis in neonates. This study
investigates phenotypic and genotypic features of C. parapsilosis microbial isolates and underlying clinical
conditions associated with acquisition of C. parapsilosis in a neonatal intensive care unit (NICU) in Italy.
Methods: Identification of C. parapsilosis was performed by VITEK® 2 and MALDI TOF and confirmed by analysis of
internal transcribed spacer ribosomal DNA sequences. Genotyping was performed by PCR fingerprinting. Antifungal
susceptibility of strains was evaluated by microdilution. A case-control study was designed to identify risk factors for
C. parapsilosis bloodstream infection.
Results: During the study period (April 2009- April 2012), C. parapsilosis was responsible for 6 umbilical catheter and
11 central catheter-associated bloodstream infection in 17 neonates in the NICU. Molecular typing identified
identical fingerprinting profile in all C. parapsilosis isolates from neonates. Fifteen of 17 C. parapsilosis isolates were
susceptible to all antifungal drugs, two isolates were resistant to fluconazole and intermediate susceptible to
itraconazole. Low birthweight, gestational age and time to exposure to assisted ventilation were risk factors for C.
parapsilosis infection in neonates in the NICU at univariate and multivariate analysis.
Conclusion: C. parapsilosis bloodstream infections in the NICU were caused by a single epidemic clone. Low
birthweight, gestational age and time to exposure to invasive devices, with predominance of assisted ventilation,
were the clinical conditions associated with C. parapsilosis bloodstream infection in the NICU.
Keywords: Candida parapsilosis, Neonatal intensive care unit, Healthcare-associated infections, Risk factor analysis,
Low birth weight
Background
Healthcare-associated infections (HAI) are frequent
complications occurring during hospitalization of
neonates in intensive care units, resulting in increased
morbidity and mortality, prolonged lengths of stay, and
increased medical costs [1, 2]. Low-birth weight and use
of central venous catheterization and mechanical ventila-
tion were identified as risk factors of HAIs in the
neonatal intensive care unit (NICU) [3–6]. Etiology of
device-associated infections in NICUs shows that
Candida spp. are among the most frequent pathogens
responsible for HAIs in NICUs, followed by gram
positive or gram negative bacteria according to different
clinical setting [1–9]. Although Candida albicans re-
mains the most frequently isolated in many centers
[9, 10], Candida parapsilosis has emerged as the most
frequent non-albicans Candida species and the pre-
dominant pathogen of invasive candidiasis in neonates
[8, 11–17]. In the tertiary care NICU of University
Hospital in Naples, Italy, C. parapsilosis was the most
frequent pathogen responsible for device-associated
bloodstream infections (BSI) during 2006–2010 [6].
Aims of the present study were to: i) analyse pheno-
typic and genotypic features of C. parapsilosis clinical
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isolates from the NICU of University Hospital in Naples,
Italy; ii) identify underlying clinical conditions associated
with C. parapsilosis bloodstream infection in the NICU.
Methods
Setting
The University of Naples “Federico II” NICU is a tertiary
care level NICU with a total of 25 incubators and
cradles. The ward serves the University Obstetric Clinic
(approximately 2000 births/year) which is both a high
risk pregnancy center and an obstetric emergency ser-
vice. Moreover, the NICU admits outborn neonates from
the regional Newborn Emergency Transport Service.
The tertiary-level NICU of the Federico II University
Hospital in Naples has approximately 350 admissions
per year. Fluconazole prophylaxis for neonates ≤1500 g
BW at dose of 6 mg/kg body weight every 72 h during
the first two weeks and then every 48 h [18] is active at
the NICU of Federico II University Hospital.
Surveillance of healthcare-associated infections
HAIs active, patient based surveillance on neonates
with >2 days NICU stay was performed as previously de-
scribed [6]. Data regarding birth (birth weight (BW),
gestational age, type of delivery, and Apgar score), inva-
sive device exposure (days of umbilical and central line
catheterization and of invasive ventilation) and infec-
tions were collected. HAIs were defined using standard
Centers for Disease Control and Prevention definitions
adapted to neonatal pathology and were considered to
be healthcare-associated if they develop >2 days after
NICU admission [19–21]. Central line-associated BSI
and umbilical catheter-associated BSI were attributed if
a central line and an umbilical catheter, respectively,
were in place at the time of or within 48 h before infec-
tion onset [21]. Surveillance swabs from the nose,
pharynx and rectum of each neonate admitted to the
ward were analyzed weekly as part of a screening
programme for surveillance of HAIs. Environmental
cultures (surfaces, including walls, floor, beds and the
drug trolley, handwashing sinks, disinfectants, equip-
ment and staff hands) were obtained using a brain
—heart broth moistened cotton swab during four envir-
onmental microbiological investigations.
Mycotic strains and microbiological methods
All C. parapsilosis clinical isolates from blood cultures
and from surveillance swabs of the patients hospitalized in
the NICU and C. parapsilosis environmental isolates from
the NICU between April 2009 and April 2012 were in-
cluded in the study. All the strains were grown on Sabour-
aud with CAF 50 mg/ml (Oxoid Basingstoke, UK) and
were identified using standard procedures i.e. morphology
on Sabourad with CAF 50 plate, determination of the
colonies color non Candida agar chromogenic medium,
microscopic examination and biochemical analysis by
VITEK® 2 automatic system (bioMèrieux Marcy-L’Etoile
France) and by MALDI TOF mass spectrometry as previ-
ously described [22]. All strains were stored at −80 °C in
glycerol solution.
Identification of C. parapsilosis group was confirmed
by PCR amplification and analysis of internal transcribed
spacer ribosomal DNA sequences [23]. Genotyping of
microbial isolates was performed by PCR fingerprinting
as previously described [24]. In brief, fingerprinting pro-
files were determined by scoring bands from GACA4,
M13, T3B and OPA-03 PCR single primers; at least 22
digits were considered for each isolate.
Antimycotic susceptibility testing
Susceptibility to amphotericin B, caspofungin, fluconazole,
itraconazole, voriconazole, posaconazole, anidulafungin,
micafungin, 5-fluorocytosine was analyzed using the col-
orimetric microdilution test Sensititre (Trek Dignostic
Systems, Ltd, East Grinstead, Sussex, UK). After overnight
growth on Sabouraud dextrose agar at 35 °C, appropriate
dilutions of each strain were prepared according to manu-
facturer’s recommendations. The Panels for the Sensititre
test were inoculated and then incubated at 35 °C in a non-
CO2 incubator. The positive growth well was examined
after 24 h incubation. If no growth was detected, the panel
was incubated for a further 24 h. MICs were determined
by visual inspection of the plates; the concentration of the
first well that remained blue (absence of growth) was re-
corded as the MIC. C. krusei ATCC 6258 and C. parapsi-
losis ATCC 22019 were used as quality control isolates.
The results of the in vitro susceptibility tests were inter-
preted according to the established CLSI MIC break-
points [25].
Study design
A retrospective case-control study was designed to
identify individual risk factors for C. parapsilosis blood-
stream infection in the NICU. Patients enrolled in the
analysis were all neonates who were in the NICU during
the study period (April 2009–April 2012) for at least
48 h and were divided into 10 groups. Cases were neo-
nates with clinical sign of neonatal sepsis and isolation
of C. parapsilosis in the bloodstream and corresponded
to group 1 of 17 patients. Controls were all neonates
without C. parapsilosis isolation who were in the NICU
for >48 h during the study period and were divided in
groups 2–10 of 75 patients each using the chronological
order from April 2009 to April 2012. Information was
obtained retrospectively from patients’ notes, and char-
acteristics and variables that were examined as possible
risk factors are listed in Table 1. Length of NICU stay
was calculated using the following formula: [(date of
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discharge from the NICU — date of admission to the
NICU) + 1].
Statistical analysis
Data were analyzed using R Statistical Package [26]. Risk
factors for acquisition of C. parapsilosis were identified
by a robust version of one-way independent ANOVA
and a non-parametric counterpart as the Kruskal-Wallis
test [27, 28]. For these univariate analyses, a p-
value ≤0.05 was considered to indicate significance. Ro-
bust Post hoc tests for multiple pairwise case-control
comparisons were run using Rand Wilcox’s functions
[27, 28]. A Robust MANOVA was conducted on the
ranked data using Munzel and Brunner’s [29] method,
implemented in R using the mulrank function [27]. Vari-
ables tested for inclusion in the multi-variate model
were those significantly associated with acquisition of C.
parapsilosis at p ≤0.05 in the univariate analysis. A sig-
nificant MANOVA was followed up using Discriminant
Function Analysis (DFA) [30].
Results
Epidemiology of C. parapsilosis in NICU
Between April 2009 to April 2012 C. parapsilosis sepsis
was diagnosed in 17 neonates, 13 males and 4 females,
in the NICU. All 17 neonates with C. parapsilosis sepsis
showed blood culture isolation (Table 1). Sixteen of the
infected patients were pre-term neonates (median gesta-
tional age 26 weeks, IQR 24 – 32) and 11 of them were
of extremely low birth weight (ELBW). The median birth
weight was 790 g (IQR 600 – 1300). The median length
of NICU stay was 48 days (IQR 26 – 86). During their
NICU stay, 94.11% patients had an umbilical catheter
(UC), 88.23% had a central venous catheter (CVC) and
94.11% underwent assisted ventilation (AV). The median
length of exposure to a UC was 6 days (IQR 4 – 7), the
median length of exposure to CVC was 22 days (IQR 14
– 37), and the median length of exposure to AV was
24 days (IQR 14 – 47). Six bloodstream infections were
associated with the use of UC, 11 with the use of CVC.
Fifty eight percent of neonates with C. parapsilosis
bloodstream infection died (Table 1).
One of the 17 neonates with C. parapsilosis blood-
stream infection showed concomitant isolation from
pharynx surveillance swab. No additional pharynx or
rectal swabs from the other 16 neonates were found
positive for C. parapsilosis. During the study period,
concomitant isolation of Candida albicans from pharynx
or rectal surveillance swabs and emocolture was ob-
served in 8 patients (data not shown). C. parapsilosis
was isolated from the wall of neonatal intensive care
room on July 2009. No C. parapsilosis isolates were ob-
tained from staff hands. All C. parapsilosis isolates were
identified to the species level and assigned to C.
parapsilosis group I by PCR amplification and analysis
of the internal transcribed spacer ribosomal DNA se-
quences. Molecular typing of C. parapsilosis isolates
identified identical PCR fingerprinting profiles in C.
parapsilosis isolates from the 17 neonates, blood culture
and pharynx swab isolates from the same patient having
identical fingerprinting profile also. In contrast, C. para-
psilosis environmental isolate showed different PCR fin-
gerprinting profiles (Additional file 1 Table S1). The
above finding excluded the contaminated environment
of the NICU as the source or reservoir of C. parapsilosis
in the ward and demonstrated the cross-transmission of
one single C. parapsilosis clone among neonates.
Antimycotic susceptibility profiles of C. parapsilosis
isolates
All C. parapsilosis isolates were susceptible to anidulafun-
gin, micafungin, caspofungin, 5-fluorocytosine, amphoteri-
cin B, posaconazole and voriconazole. Fluconazole
resistance was detected in two isolates (MICs 128 μg/mL
and 64 μg/mL, respectively), intermediate susceptibility to
itraconazole (MIC 0.25 μg/mL) was detected in one of the
above two isolates (Table 2). Both fluconazole-resistant C.
parapsilosis isolates were from neonates ≤1500 g BW.
Risk factor analysis
Figure 1 showed the boxplots for covariates counts in
cases and control groups, whereas Fig. 2 showed that
the overall sampling distributions were not normally dis-
tributed. Moreover, in the case of duration of use of
CVC and duration of use of AV, the variances in differ-
ent groups were different as stated by the Levene’s Test
for Homogeneity of Variance (p <0.001). Instead, dur-
ation of use of umbilical catheter, gestational age, birth
weight, and length of NICU stay, showed homogeneity
of variance in different groups. Moreover, except for the
cases of gestational age, birth weight, and length of
NICU stay, we cannot assume normality of residuals er-
rors. For these reasons, both a Robust ANOVA method,
Table 2 Antimycotic susceptibility profiles of C. parapsilosis isolates
Antifungal Agents MIC50 (μg/mL) MIC90 (μg/mL) MIC range (μg/mL)
Anidulafungin 1 2 0.5–2
Micafungin 2 2 1–2
Caspofungin 0.5 1 0.25–2
5-fluorocytosine 0.25 0.5 0.12–0.5
Posaconzole 0.06 0.125 0.03–0,125
Voriconazole 0.03 0.5 0.008–1
Itraconazole 0.12 0.25 0.06–0,25
Fluconazole 1 64 0.5–128
Amphotericin B 0.5 1 0.5–1
MIC minimal inhibitory concentration
Garzillo et al. Italian Journal of Pediatrics  (2017) 43:10 Page 4 of 9
based on bootstrapping and/or trimmed means and M-
estimators, and a non-parametric method, such as
Kruskal-Wallis were used for risk factor analysis. Add-
itional file 1 Table S2 showed also Post hoc tests, i.e.
pairwise comparisons that were designed to compare all
different combinations of the treatment groups, for both
methods. Univariate analysis showed that C. parapsilosis
bloodstream infection was significantly related to gesta-
tional age, birth weight, duration of use of UC, CVC and
AV, but not to length of NICU stay.
MANOVA multivariate analysis was performed to de-
tect the relationship among outcome variables and the dif-
ferences of groups along a combination of dimensions.
Robust MANOVA results showed a significant effect for
acquisition of C. parapsilosis: F = 3.043, p <0.001. More-
over, the rank values of duration of use of AV (.72), Gesta-
tional Age (.75), and Birth Weight (.88), were greater in
cases (group 1) than controls (groups 2–10) (Table 3).
The reverse was true for duration of use of CVC (.17), and
duration of use of Umbilical Catheter (.19): the ranks of
the cases were lower than those of the controls (Table 3).
Next, discriminant function analysis was performed to dis-
tinguish a set of groups using several predictors. The ratio
of systematic to unsystematic variance was maximized for
this first group, with subsequent groups having smaller
values, as shown by the trend of proportion of trace in
Table 4. Hence, the coefficients measured the relative
contribution of each variable to the discrimination among
the groups. Noteworthy, gestational age and birth weight
were highly correlated with rho = 0.841 (Spearman’s rank
test p-value <0.01), thus resulting as a single predictor in
DFA. Discriminant analysis revealed five discriminant
functions (Table 4). The proportion of trace showed that
the first group (practically gestational age) accounted for
54.5% of variance compared to the second group (gesta-
tional age plus duration of use of UC and duration of use
of AV), which accounted for 22.2%. The third group (ges-
tational age plus duration of use of AV) accounted for
12.3%, while the fourth and the fifth groups accounted for
7.1%, and 4.0%, respectively.
Discussion
C. parapsilosis is an increasing cause of healthcare-
associated infections and in particular device-associated
blood stream infections in the NICU [6, 11–13, 31]. In
the tertiary care level NICU of University Hospital in
Naples, Italy, C. parapsilosis was responsible for 50%
and 35% of UC-associated and CVC-associated blood-
stream infections during 2006–2010 [6].
The data presented here demonstrate that a single
clone of C. parapsilosis was responsible for UC or CVC-
associated bloodstream infections in 17 neonates from
Fig. 1 Boxplots for covariates counts in each group. Group 1 represents the cases, groups 2–10 represent the controls. The circles that lie above
the top whiskers are the outliers
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our NICU from April 2009 to April 2012. C. parapsilosis
strains assigned to C. parapsilosis group I and showing
identical PCR fingerprinting profiles were isolated from
blood cultures of all 17 neonates and pharynx swab of 1
neonate, while C. parapsilosis environmental isolate
showed different PCR fingerprinting profiles. A previous
study showed that that the increase of C. parapsilosis
bloodstream infections in a NICU in Helsinki, Finland
was caused by the spread of a single clone with identical
DNA fingerprinting profile [14]. In accordance with pre-
vious findings [13, 14], the majority (15 out of 17) C.
parapsilosis isolates were susceptible to echinocandins,
Fig. 2 Histograms of variable distributions. Sampling distributions are not normally distributed
Table 3 Relative effect of Robust MANOVA
Group Duration of use of CVC Duration of use of UC Duration of use of AV Gestational Age Birth Weight
1 0.167 0.186 0.720 0.745 0.877
2 0.479 0.394 0.531 0.494 0.490
3 0.395 0.384 0.559 0.540 0.488
4 0.555 0.548 0.567 0.608 0.531
5 0.501 0.514 0.428 0.575 0.462
6 0.515 0.527 0.483 0.488 0.534
7 0.443 0.424 0.539 0.428 0.523
8 0.549 0.518 0.471 0.426 0.409
9 0.552 0.568 0.426 0.424 0.450
10 0.543 0.547 0.464 0.504 0.559
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azoles, 5-fluorocytosine and amphotericin B, but 2 were
resistant to fluconazole and one resistant to fluconazole
and intermediate resistant to itraconazole. The occur-
rence of resistance to fluconazole in C. parapsilosis iso-
lates from 2 out of 14 neonates ≤1500 g BW under
fluconazole prophylaxis is in agreement with previous
study showing that fluconazole prophylaxis increase the
incidence of invasive infections involving fluconazole-
resistant C. parapsilosis [31].
Molecular typing data presented herein exclude the
environment as the source or reservoir of C. parapsilosis
in the ward. Also, the absence of isolation of C. parapsi-
losis from the pharynx or rectal swabs in 16 neonates
with C. parapsilosis bloodstream infection and the con-
comitant isolation of C. parapsilosis from pharynx swab
and emocolture in only 1 neonate suggest that mucosal
colonization by C. parapsilosis does not precede invasive
infection as observed for C. albicans bloodstream infec-
tion. Although our data did not identify the route of
transmission of C. parapsilosis among neonates in the
NICU, the assignment of all C. parapsilosis clinical iso-
lates to a single epidemic genotype suggests that infected
neonates were the reservoir and source of C. parapsilosis
epidemic in the NICU.
Several studies analyzed risk factors for neonatal candid-
iasis without distinguishing among isolated Candida
species [7–11], while few studies analyzed risk factors for
invasive C. parapsilosis infections in neonates by univari-
ate analysis [13–15] or multivariate analysis [15–17].
Neonatal risk factors for invasive C. parapsilosis infections
were birth weight <1500 g, prematurity, prior colonization,
parenteral nutrition, intravascular catheters and use of an-
tibiotics, steroids and H2 blockers (13–15). Similarly, we
found that birth weight, gestational age, time to exposure
to UC, CVC, and AV were risk factors for C. parapsilosis
infection in neonates in the NICU at univariate analysis.
In a case-control population-based study on 78 episodes
of C. parapsilosis fungemia compared with 175 C. albicans
controls, neonate patients, transplant patients, and
patients who received antifungal therapy or parenteral nu-
trition were significantly associated with C. parapsilosis
bloodstream infection on multivariate analysis [15]. When
non-albicans Candida species bloodstream infections in-
cluding those caused by C. parapsilosis were compared
with C. albicans bloodstream infections, multivariate
logistic regression analysis identified neonatal age,
fluconazole exposure and having received an
hematological transplant as factors associated with a
risk of candidemia caused by non-albicans Candida
species [16]. Risk factors analysis of nosocomial can-
didemia in an adult intensive care unit (ICU) and a
NICU in Brazil identified sex and parenteral nutrition
as independent risk factors of C. parapsilosis blood-
stream infections, which were more frequent in NICU
than in adult ICU [17]. In agreement with these
findings, we identified low birth weight and gesta-
tional age (explaining more than 55.0% of the vari-
ance) as risk factors for C. parapsilosis bloodstream
infection in neonates in the NICU. Moreover, we
demonstrated that time to exposure to invasive de-
vices (explaining ca 34.0% of the variance), with pre-
dominance of assisted ventilation, is independent risk
for C. parapsilosis bloodstream infection in neonates
in the NICU at multivariate analysis. Based on our
data, we speculate that prematurity and extremely low
birth weight (<1000 g) and any manoeuvre associated
with AV usage may have been involved in the trans-
mission between patients and acquisition of C. para-
psilosis infections in our NICU.
We recognize that our study has limitations that affect
the generalization of our results. The first limitation re-
lies on the retrospective nature of the study, which did
not allow to evaluate the efficacy of specific infection
prevention measures against C. parapsilosis bloodstream
infection in the NICU. For example, the appropriateness
of antifungal prophylaxis was not assessed by our study
despite the isolation of two C. parapsilosis isolates resist-
ant to fluconazole. Additional limitation of the study
was the lack of analysis of inborn and outborn status,
mortality, total parenteral nutrition, probiotics adminis-
tration, days and type of antenatal and postnatal anti-
biotic use and other concomitant drugs therapeutic
variables of neonates included in the study. Future stud-
ies will be necessary to investigate the above issues.
Conclusion
C. parapsilosis UC or CVC-associated bloodstream infec-
tions in our NICU were caused by the spread of a single
epidemic clone. Low birth weight, gestational age, dur-
ation of use of UC, duration of use of CVC, duration of
use of AV were risk factors for C. parapsilosis infection in
neonates in the NICU at univariate analysis. Low birth
weight, gestational age and time to exposure to AV were
identified as principal independent risk factors for C.
parapsilosis bloodstream at multivariate analysis. Surveil-
lance of device-associated infections are necessary to pre-
vent C. parapsilosis bloodstream infections in the NICU.
Table 4 Discriminant Function Analysis
LD1 LD2 LD3 LD4 LD5
Duration of use of CVC −0.033 −0.102 0.058 0.076 0.007
Duration of use of UC 0.002 0.105 −0.118 0.227 −0.147
Duration of use of AV −0.033 0.111 0.111 −0.042 0.025
Gestational Age 0.228 0.149 0.149 0.247 0.262
Birth Weight −0.0002 −0.0003 −0.0003 −0.0005 −0.002
Proportion of trace 0.545 0.222 0.123 0.071 0.040
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Additional file
Additional file 1: Table S1. PCR fingerprinting profiles of C. parapsilosis
isolates. Table S2. Robust ANOVA and Kruskal-Wallis tests. (PDF 71 kb)
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